Page 23 - EJMO-9-2

Eurasian Journal of
Medicine and Oncology Single-cell sequencing for lung cancer

doi: 10.1038/s41467-021-26770-2 immune profile in a pembrolizumab-responsive PD-L1-
negative lung cancer patient. Cancer Immunol Immunother.
61. Zhang Y, Du W, Chen Z, Xiang C. Upregulation of PD-L1
by SPP1 mediates macrophage polarization and facilitates 2021;70(8):2261-2274.
immune escape in lung adenocarcinoma. Exp Cell Res. doi: 10.1007/s00262-021-02848-0
2017;359(2):449-457.
72. Hu Y, Xu C, Ren J, et al. Exposure to tobacco smoking
doi: 10.1016/j.yexcr.2017.08.028 induces a subset of activated tumor-resident tregs in non-
62. Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: Current small cell lung cancer. Transl Oncol. 2022;15(1):101261.
technology and clinical applications. J Hematol Oncol. doi: 10.1016/j.tranon.2021.101261
2022;15(1):131.
73. Ruan H, Zhou Y, Shen J, et al. Circulating tumor cell
doi: 10.1186/s13045-022-01351-y characterization of lung cancer brain metastases in the
63. Li X, Li M, Huang M, et al. The multi-molecular cerebrospinal fluid through single-cell transcriptome
mechanisms of tumor-targeted drug resistance in precision analysis. Clin Transl Med. 2020;10(8):e246.
medicine. Biomed Pharmacother/Biomed Pharmacother. doi: 10.1002/ctm2.246
2022;150:113064.
74. Wang G, Qiu M, Xing X, et al. Lung cancer scRNA-seq and
doi: 10.1016/j.biopha.2022.113064 lipidomics reveal aberrant lipid metabolism for early-stage
64. Xu M, Zhao H, Chen J, et al. An integrated microfluidic chip diagnosis. Sci Transl Med. 2022;14(630):eabk2756.
and its clinical application for circulating tumor cell isolation doi: 10.1126/scitranslmed.abk2756
and single-cell analysis. Cytometry A. 2020;97(1):46-53.
75. Tang Y, Kwiatkowski DJ, Henske EP. Midkine expression by
doi: 10.1002/cyto.a.23902
stem-like tumor cells drives persistence to mTOR inhibition
65. Su Z, Wang Z, Ni X, et al. Inferring the evolution and and an immune-suppressive microenvironment. Nat
progression of small-cell lung cancer by single-cell Commun. 2022;13(1):5018.
sequencing of circulating tumor cells. Clin Cancer Res. doi: 10.1038/s41467-022-32673-7
2019;25(16):5049-5060.
76. Filippou PS, Karagiannis GS, Constantinidou A. Midkine
doi: 10.1158/1078-0432.Ccr-18-3571
(MDK) growth factor: A key player in cancer progression
66. Chang Y, Wang Y, Li B, et al. Whole-exome sequencing on and a promising therapeutic target. Oncogene. 2020;39(10):
circulating tumor cells explores platinum-drug resistance 2040-2054.
mutations in advanced non-small cell lung cancer. Front
Genet. 2021;12:722078. doi: 10.1038/s41388-019-1124-8
77. Jiang A, Wang J, Liu N, et al. Integration of single-cell RNA
doi: 10.3389/fgene.2021.722078
sequencing and bulk RNA sequencing data to establish
67. Negishi R, Yamakawa H, Kobayashi T, et al. Transcriptomic and validate a prognostic model for patients with lung
profiling of single circulating tumor cells provides insight adenocarcinoma. Front Genet. 2022;13:833797.
into human metastatic gastric cancer. Commun Biol.
2022;5(1):20. doi: 10.3389/fgene.2022.833797
doi: 10.1038/s42003-021-02937-x 78. Aleksakhina SN, Kashyap A, Imyanitov EN. Mechanisms of
acquired tumor drug resistance. Biochim Biophys Acta Rev
68. Andrikou K, Rossi T, Verlicchi A, et al. Circulating tumour Cancer. 2019;1872(2):188310.
cells: Detection and application in advanced non-small cell
lung cancer. Int J Mol Sci. 2023;24(22):16085. doi: 10.1016/j.bbcan.2019.188310
doi: 10.3390/ijms242216085 79. Vasan N, Baselga J, Hyman DM. A view on drug resistance
in cancer. Nature. 2019;575(7782):299-309.
69. Kim J, Xu Z, Marignani PA. Single-cell RNA sequencing
for the identification of early-stage lung cancer biomarkers doi: 10.1038/s41586-019-1730-1
from circulating blood. NPJ Genomic Med. 2021;6(1):87. 80. Zhang A, Miao K, Sun H, Deng CX. Tumor heterogeneity
doi: 10.1038/s41525-021-00248-y reshapes the tumor microenvironment to influence drug
resistance. Int J Biol Sci. 2022;18(7):3019-3033.
70. Kagamu H, Yamasaki S, Kitano S, et al. Single-cell analysis
reveals a CD4+ T-cell cluster that correlates with PD-1 doi: 10.7150/ijbs.72534
blockade efficacy. Cancer Res. 2022;82(24):4641-4653. 81. Wang X, Zhang H, Chen X. Drug resistance and combating
doi: 10.1158/0008-5472.Can-22-0112 drug resistance in cancer. Can Drug Resist. 2019;2(2):
141-160.
71. Zhong R, Zhang Y, Chen D, Cao S, Han B, Zhong H.
Single-cell RNA sequencing reveals cellular and molecular doi: 10.20517/cdr.2019.10

Volume 9 Issue 2 (2025) 15 doi: 10.36922/ejmo.6883